4//SEC Filing
Kelley Robert J. 4
Accession 0001209191-21-059487
CIK 0001584751other
Filed
Oct 4, 8:00 PM ET
Accepted
Oct 5, 4:48 PM ET
Size
5.6 KB
Accession
0001209191-21-059487
Insider Transaction Report
Form 4
Kelley Robert J.
Chief Commercial Officer
Transactions
- Award
Stock Option (right to buy)
2021-10-02+130,000→ 427,202 totalExercise: $6.17Exp: 2031-10-01→ Common Stock (130,000 underlying)
Footnotes (2)
- [F1]25% of the shares underlying this option shall vest on the first annual anniversary of the vesting commencement date and 1/48th of the shares underlying this option shall vest monthly thereafter over 36 months.
- [F2]Price not required on initial report of stock option granted.
Documents
Issuer
Talis Biomedical Corp
CIK 0001584751
Entity typeother
Related Parties
1- filerCIK 0001845542
Filing Metadata
- Form type
- 4
- Filed
- Oct 4, 8:00 PM ET
- Accepted
- Oct 5, 4:48 PM ET
- Size
- 5.6 KB